Groups

Research Focus

Former Employee. Commack; Clinical Nurse III

Recent additions – View all

1. A phase I study of AZD9496, a novel oral, selective estrogen receptor degrader (SERD) in women with estrogen receptor positive, HER-2 negative advanced breast cancer (ABC)

   Meeting Abstract

   Hamilton, E.; Patel, M.; Armstrong, A.; Baird, R.; Jhaveri, K.; Hoch, M.; Morgan, S.; Dowdall, T.; Schiavon, G.; Klinowska, T.; more...
   Cancer Research (2017)

   Fulltext@MSK | Save